SCHEMBL4631202

SCHEMBL4631202

C[C@@H](c1ccccc1)N1CCOCC1

nearest known ligand 0.73

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 1/20 0.73
MC4R P32245 1/20 0.63
ALDH1A1 P00352 4/20 0.58
CYP3A4 P08684 2/20 0.58
TSHR P16473 2/20 0.58
CYP2C19 P33261 1/20 0.58
LTA4H P09960 1/20 0.55
KCNA5 P22460 2/20 0.53
OPRM1 P35372 1/20 0.53
OPRD1 P41143 1/20 0.53
OPRK1 P41145 1/20 0.53
OPRL1 P41146 1/20 0.53
HIF1A Q16665 1/20 0.49
GRM5 P41594 1/20 0.49
LMNA P02545 2/20 0.48
L3MBTL1 Q9Y468 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2485451 1.00 CYP2D6 (0.73) CYP2D6MC4RALDH1A1CYP3A4TSHR
Hydrochloric Acid SCHEMBL28177303 0.98 CYP2D6 (0.70) CYP2D6MC4RALDH1A1CYP3A4TSHR
SCHEMBL6706135 0.85 CYP2D6 (1.00) CYP2D6MC4RALDH1A1CYP3A4CYP2C19
SCHEMBL7264542 0.85 CYP2D6 (1.00) CYP2D6MC4RALDH1A1CYP3A4CYP2C19
SCHEMBL16226061 0.85 CYP2D6 (1.00) CYP2D6MC4RALDH1A1CYP3A4CYP2C19
SCHEMBL23850144 0.81 CYP2D6 (0.83) CYP2D6MC4RALDH1A1CYP3A4CYP2C19
SCHEMBL30364156 0.81 CYP2D6 (0.83) CYP2D6MC4RALDH1A1CYP3A4CYP2C19
SCHEMBL8983562 0.81 CYP2D6 (0.83) CYP2D6MC4RALDH1A1CYP3A4TSHR
SCHEMBL8983627 0.81 CYP2D6 (0.83) CYP2D6MC4RALDH1A1CYP3A4TSHR
SCHEMBL7097730 0.81 CYP2D6 (0.83) CYP2D6MC4RALDH1A1CYP3A4TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3091012-B1 CCR2 RECEPTOR ANTAGONISTS AND USES THEREOF CENTREXION THERAPEUTICS CORP (US) 2018-04-11 EP disclosed
EP-1910320-A2 INTERMEDIATE COMPOUND FOR SYNTHESIZING PHARMACEUTICAL AGENT AND PRODUCTION METHOD THEREOF Mitsubishi Tanabe Pharma Corporation (JP) 2008-04-16 EP disclosed
WO-2007011065-A2 INTERMEDIATE COMPOUND FOR SYNTHESIZING PHARMACEUTICAL AGENT AND PRODUCTION METHOD THEREOF MITSUBISHI TANABE PHARMA CORPORATION (JP) 2007-01-25 WO disclosed